Loading
PL
Pacgen Life Science Corporation Stock: price and insider trades · Canada
Pacgen Life Science Corporation: what insiders have been doing
Pacgen Life Science Corporation is a listed company. Filings by its managers are published through SEDI. Pacgen Life Science Corporation has had no insider filing for more than a year; the last one goes back to 6 October 2020.
Since 2016, the database holds 68 purchases and 2 sales by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
81
Thresholds
n/a
Buy Volume
€158,456
68 ops. · all time
Sell Volume
€584
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 6 October 2020
Declarations81 total
155,000 shares@ CA$0.0275Common SharesTSXSEDI:3612424
5,408,333 shares@ CA$0.0275Common SharesTSXSEDI:3612422
1,333,333 shares@ CA$0.0672.0% of flowCommon SharesTSXSEDI:3318900
Canonical exit: 9 Aug 2018 (T+90)
2,000 shares@ CA$0.070.1% of flowCommon SharesTSXSEDI:3171204
Canonical exit: 11 Jul 2018 (T+90)
4,000 shares@ CA$0.0650.2% of flowCommon SharesTSXSEDI:3171203
Canonical exit: 11 Jul 2018 (T+90)
15,000 shares@ CA$0.060.8% of flowCommon SharesTSXSEDI:3164536
Canonical exit: 1 Jul 2018 (T+90)
18,000 shares@ CA$0.060.7% of flowCommon SharesTSXSEDI:3139913
Canonical exit: 23 May 2018 (T+90)
Common SharesTSXSEDI:3117916
1,075,000 shares@ CA$0.06100.0% of flowCommon SharesTSXSEDI:3117910
2,475,000 shares@ CA$0.0695.0% of flowCommon SharesTSXSEDI:3117908
23,000 shares@ CA$0.0751.6% of flowCommon SharesTSXSEDI:3117206
Canonical exit: 11 Apr 2018 (T+90)
2,000 shares@ CA$0.0650.1% of flowCommon SharesTSXSEDI:3117207
Canonical exit: 11 Apr 2018 (T+90)
5,000 shares@ CA$0.060.1% of flowCommon SharesTSXSEDI:3098288
Canonical exit: 13 Mar 2018 (T+90)
4,014,000 sharesCommon SharesTSXSEDI:3040950
4,014,000 sharesCommon SharesTSXSEDI:3040953
Common SharesTSXSEDI:3037313
100,000 shares@ CA$0.05572.5% of flowCommon SharesTSXSEDI:3025231
Canonical exit: 20 Sept 2017 (T+90)
13,000 shares@ CA$0.0610.3% of flowCommon SharesTSXSEDI:3024589
Canonical exit: 20 Sept 2017 (T+90)
7,000 shares@ CA$0.065.5% of flowCommon SharesTSXSEDI:3024152
Canonical exit: 19 Sept 2017 (T+90)
10,000 shares@ CA$0.0911.8% of flowCommon SharesTSXSEDI:3007455
Canonical exit: 10 Aug 2017 (T+90)
100,000 sharesCommon SharesTSXSEDI:3003378
3,000 shares@ CA$0.0850.3% of flowCommon SharesTSXSEDI:2959077
Canonical exit: 17 May 2017 (T+90)
12,000 shares@ CA$0.0851.0% of flowCommon SharesTSXSEDI:2958230
Canonical exit: 16 May 2017 (T+90)
2,000 shares@ CA$0.070.1% of flowCommon SharesTSXSEDI:2950160
Canonical exit: 30 Apr 2017 (T+90)
10,000 shares@ CA$0.080.8% of flowCommon SharesTSXSEDI:2950158
Canonical exit: 30 Apr 2017 (T+90)
25 of 81 declarations
About Pacgen Life Science Corporation
Pacgen Life Science Corporation is a biotechnology company focused on developing treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
